Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection

NCT04260789 is registered in ClinicalTrials.gov with ExThera Medical Europe BV as lead sponsor.

NCT NCT04260789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04260789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection
Lead sponsor
ExThera Medical Europe BV
Phase
Not applicable
Overall status
Unknown status
Start date
August 19, 2020
Completion date
August 1, 2022
Enrollment
232 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection